Company: QTIWW
Filing Date: 2025-01-16
Form Type: S-1
Source: 0001628280-25-001723
Chunk: 173

Company: QT IMAGING HOLDINGS, INC.
Filing Date: 2025-01-16
Form: S-1
Chunk 173
---
 and surrendered the Extension Note on November 22, 2024 for cancellation in its entirety in exchange for the purchase of PIPE Shares and PIPE Warrants for the purchase of Common Stock with a purchase price of $1,560,000.

#### Cash Flows
The following table provides information regarding our cash flows for the periods presented:

|                                                                          |     | 2024 | For Nine Months Ended 
         September 30, |     | 2023 |            |     | 2023 | For Years Ended 
    December 31, |     | 2022 |            |
|:-------------------------------------------------------------------------|:----|:-----|----------------------:|:----|:-----|-----------:|:----|:-----|----------------:|:----|:-----|-----------:|
| Net cash used in operating activities                                    |     | $    |            -8,806,402 |     | $    | -1,965,772 |     | $    |      -2,651,143 |     | $    | -3,861,735 |
| Net cash used in investing activities                                    |     |      |               -34,590 |     |      |    -25,995 |     |      |         -13,040 |     |      |    -22,600 |
| Net cash provided by financing activities                                |     |      |            10,220,475 |     |      |  1,571,181 |     |      |       2,373,793 |     |      |  2,779,729 |
| Net increase (decrease) in cash and restricted cash and cash equivalents |     | $    |             1,379,483 |     | $    |   -420,586 |     | $    |        -290,390 |     | $    | -1,104,606 |

#### Net Cash Used In Operating Activities
Net cash used in operating activities was $8,806,402 for the nine months ended September 30, 2024 as compared to $1,965,772 for the nine months ended September 30, 2023. The primary use of our cash was to fund research and development and general and administrative expenses. Net cash used for the nine months ended September 30, 2024 consisted of a net loss of $9,166,958, adjusted for non-cash expenses primarily including depreciation and amortization of $204,283, stock-based compensation of